diffuse large cell lymphoma
Showing 1 - 19 of 19
Diffuse Large Cell Lymphoma, Non-Hodgkin Lymphoma, Burkitt Lymphoma Trial run by the National Cancer Institute (NCI)
Recruiting
- Diffuse Large Cell Lymphoma
- +4 more
- Vincristine
- +6 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Mantle Cell Lymphoma, Diffuse Large Cell Lymphoma, Burkitts Lymphoma Trial in Providence (cellular immunotherapy)
Terminated
- Mantle Cell Lymphoma
- +4 more
- cellular immunotherapy
-
Providence, Rhode Island
- +1 more
Feb 23, 2022
Diffuse Large Cell Lymphoma, Burkitt's Lymphoma, High Grade B-cell Lymphoma Trial in United States (Rituximab, IT Cytarabine)
Completed
- Diffuse Large Cell Lymphoma
- +2 more
- Rituximab
- IT Cytarabine
-
Buffalo, New York
- +4 more
Oct 29, 2021
Acute Lymphocytic Leukemia, Diffuse Large Cell Lymphoma Trial in Philadelphia (huCART19)
Completed
- Acute Lymphocytic Leukemia
- Diffuse Large Cell Lymphoma
- huCART19
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Sep 22, 2021
Diffuse Large Cell Lymphoma, Lymphoma Trial in Houston (Zevalin, Carmustine, Etoposide)
Completed
- Diffuse Large Cell Lymphoma
- Lymphoma
- Zevalin
- +6 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 12, 2021
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Burkitt Lymphoma Trial in Cincinnati (CPX-351)
Completed
- Acute Myeloid Leukemia
- +7 more
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Nov 6, 2020
Cancer, Chronic Lymphocytic Leukemia, Diffuse Large Cell Lymphoma Trial in Hackensack, Durham, Salt Lake City (AMG 319)
Completed
- Cancer
- +13 more
- AMG 319
-
Hackensack, New Jersey
- +2 more
Feb 8, 2017
Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Follicular Lymphoma Trial in Suzhou (anti-CD19 CAR-NK cells)
Unknown status
- Acute Lymphocytic Leukemia
- +5 more
- anti-CD19 CAR-NK cells
-
Suzhou, Jiangsu, ChinaPersonGen BioTherapeutics (Suzhou) Co., Ltd.
Dec 4, 2016
Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Follicular Lymphoma Trial in Suzhou (PCAR-019 (anti-CD19 CAR-T cells))
Unknown status
- Acute Lymphocytic Leukemia
- +5 more
- PCAR-019 (anti-CD19 CAR-T cells)
-
Suzhou, Jiangsu, ChinaPersonGen BioTherapeutics (Suzhou) Co., Ltd.
Oct 23, 2016
Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Follicular Lymphoma Trial in Suzhou (PCAR-019 (anti-CD19 CAR-T cells))
Unknown status
- Acute Lymphocytic Leukemia
- +5 more
- PCAR-019 (anti-CD19 CAR-T cells)
-
Suzhou, Jiangsu, ChinaPersonGen BioTherapeutics (Suzhou) Co., Ltd.
Jul 28, 2016
Non-Hodgkin's Lymphoma, Follicular Lymphoma, Diffuse Large Cell Lymphoma Trial in La Jolla (ISF35)
Terminated
- Non-Hodgkin's Lymphoma
- +5 more
- ISF35
-
La Jolla, CaliforniaUniversity of California, San Diego Moores Cancer Center
Nov 30, 2015
Diffuse Large Cell Lymphoma Trial in Belgium, France, Switzerland (Darbepoetin alfa)
Completed
- Diffuse Large Cell Lymphoma
- Darbepoetin alfa
-
Gent, Belgium
- +13 more
Sep 1, 2015
Diffuse Large Cell Lymphoma Trial in France (Gemcitabine-Oxaliplatin plus Rituximab (R-GEMOX))
Completed
- Diffuse Large Cell Lymphoma
- Gemcitabine-Oxaliplatin plus Rituximab (R-GEMOX)
-
Créteil, France
- +7 more
Sep 1, 2015
Non-Hodgkin's Lymphoma, Diffuse Large Cell Lymphoma, Mantle Cell Lymphoma Trial in Stanford (Rituximab 375 mg/m2)
Completed
- Non-Hodgkin's Lymphoma
- +5 more
- Rituximab 375 mg/m2
-
Stanford, CaliforniaStanford University Medical Center
Sep 4, 2014
Hodgkin's Lymphoma, Low Grade Lymphoma, Lymphoma Trial (AMG 655, Vorinostat, Bortezomib)
Completed
- Hodgkin's Lymphoma
- +5 more
- AMG 655
- +2 more
- (no location specified)
Mar 3, 2014
Leukemia, Chronic Myeloid Leukemia, Myelodysplastic Syndrome Trial in Italy (Treosulfan IV)
Unknown status
- Leukemia
- +6 more
- Treosulfan IV
-
San Giovanni Rotondo, Foggia, Italy
- +11 more
Aug 10, 2009